Status:
TERMINATED
ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy
Lead Sponsor:
Tampere University Hospital
Conditions:
Pancreatic Cancer
Surgery--Complications
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
In the study, the enhanced recovery after surgery (ERAS) program is applied to total pancreatectomy (TP) and low-risk pancreaticoduodenectomy (PD) patients identified by a small number of acinar cells...
Detailed Description
In the study, the enhanced recovery after surgery (ERAS) program is applied to total pancreatectomy (TP) and low-risk pancreaticoduodenectomy (PD) patients identified by a small number of acinar cells...
Eligibility Criteria
Inclusion
- All PD or TP patients 18-99 years old
Exclusion
- Any other surgery than PD or TP
- High risk patients
- Refusal for the study
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03757455
Start Date
September 1 2020
End Date
October 1 2021
Last Update
December 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital Deparment of Gastroenterologic Surgery
Tampere, Finland, 33521